| 2024-02-23 |
股东大会：
将于2024-03-28召开股东大会
会议内容 ▼▲
- 1.To consider and vote upon a proposal to approve the sale of substantially all of the assets of the Company, or the Asset Sale, pursuant to the Asset Purchase Agreement dated December 22, 2023, or the Asset Purchase Agreement, by and between the Company and Immunome, Inc. or Immunome. This proposal is referred to as the Asset Sale Proposal.
2.To approve the liquidation and dissolution of the Company, or the Dissolution, pursuant to the Plan of Complete Liquidation and Dissolution, or the Plan of Dissolution, which, if approved, will authorize the Company to liquidate and dissolve the Company in accordance with the Plan of Dissolution. This proposal is referred to as the Dissolution Proposal.
3.To grant discretionary authority to our Board of Directors, or the Board of Directors, to adjourn the Special Meeting, even if a quorum is present, to solicit additional proxies in the event that there are insufficient shares present virtually or represented by proxy voting in favor of either the Asset Sale Proposal or the Dissolution Proposal. This proposal is referred to as the Adjournment Proposal.
|
| 2024-02-23 |
详情>>
股本变动：
变动后总股本3962.41万股
|
| 2023-12-26 |
复牌提示：
2023-12-26 08:25:00 停牌，复牌日期 2023-12-26 09:00:00
|
| 2023-11-14 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-1.95美元,归母净利润-7641.1万美元,同比去年增长-0.79%
|
| 2023-08-10 |
详情>>
业绩披露：
2023年中报每股收益-1.03美元,归母净利润-4019.6万美元,同比去年增长23.80%
|
| 2023-08-02 |
详情>>
内部人交易：
Courtney Phillips等共交易4笔
|
| 2023-05-10 |
详情>>
业绩披露：
2023年一季报每股收益-0.54美元,归母净利润-2101万美元,同比去年增长15.54%
|
| 2023-04-27 |
股东大会：
将于2023-06-13召开股东大会
会议内容 ▼▲
- 1.To elect three Class I directors nominated by the Company’s Board of Directors to serve until the 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal;
2.To ratify the selection of WithumSmith+Brown, PC as the independent registered public accounting firm of the Company for the year ending December 31, 2023;
3.To conduct any other business properly brought before the Annual Meeting or any adjournment or postponement thereof.
|
| 2023-03-29 |
详情>>
业绩披露：
2022年年报每股收益-2.52美元,归母净利润-9715.7万美元,同比去年增长11.13%
|
| 2023-03-29 |
财报披露：
美东时间 2023-03-29 盘后发布财报
|
| 2022-11-10 |
详情>>
业绩披露：
2022年三季报(累计)每股收益-1.97美元,归母净利润-7581.2万美元,同比去年增长5.01%
|
| 2022-08-08 |
详情>>
业绩披露：
2022年中报每股收益-1.38美元,归母净利润-5275.3万美元,同比去年增长-0.58%
|
| 2022-05-11 |
详情>>
业绩披露：
2022年一季报每股收益-0.65美元,归母净利润-2487.6万美元,同比去年增长3.49%
|
| 2022-04-28 |
股东大会：
将于2022-06-08召开股东大会
会议内容 ▼▲
- 1.to elect three Class III directors nominated by the Company’s Board of Directors to serve until the 2025 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal;
2.to ratify the selection of WithumSmith+Brown, PC as the independent registered public accounting firm of the Company for the year ending December 31, 2022;
3.to conduct any other business properly brought before the Annual Meeting or any adjournment thereof.
|
| 2022-03-03 |
详情>>
业绩披露：
2021年年报每股收益-2.95美元,归母净利润-1.09亿美元,同比去年增长-26.63%
|
| 2021-11-02 |
详情>>
业绩披露：
2021年三季报(累计)每股收益-2.16美元,归母净利润-7980.8万美元,同比去年增长-26.02%
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-08-11 |
详情>>
业绩披露：
2021年中报每股收益-1.42美元,归母净利润-5245万美元,同比去年增长-29.83%
|
| 2021-04-28 |
股东大会：
将于2021-06-09召开股东大会
会议内容 ▼▲
- 1.to elect three Class II directors nominated by the Company’s Board of Directors to serve until the 2024 Annual Meeting of Stockholders and until their successors are duly elected and qualified;
2.to ratify the selection of OUM & Co. LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2021;
3.to conduct any other business properly brought before the Annual Meeting or any adjournment thereof.
|
| 2020-04-29 |
股东大会：
将于2020-06-10召开股东大会
会议内容 ▼▲
- 1.to elect two Class I directors nominated by the Company's Board of Directors to serve until the 2023 Annual Meeting of Stockholders and until their successors are duly elected and qualified;
2.to ratify the selection of OUM & Co. LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2020;
3.to conduct any other business properly brought before the Annual Meeting or any adjournment thereof.
|